Related Experiment Video
Updated: Aug 5, 2026

Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
Managing Gestational Diabetes Complexity with Continuous Glucose Monitoring: A Narrative Review
Anca-Elena Crăciun1,2, Dana Mihaela Ciobanu2,3, Georgeta Inceu2,3
1Department of Medical Sciences, Faculty of Nursing and Health Sciences, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.
Continuous glucose monitoring (CGM) aids in managing gestational diabetes (GDM) by providing real-time glucose data for timely interventions. This technology supports better maternal and infant outcomes, though cost and access remain challenges.
Area of Science:
- Endocrinology
- Maternal-Fetal Medicine
- Medical Technology
Background:
- Gestational diabetes (GDM) poses risks to mother and child, necessitating accurate glucose monitoring for effective management.
- Current GDM management relies on lifestyle changes and pharmacotherapy, contingent on precise glucose level tracking.
Purpose of the Study:
- To review the utility of Continuous Glucose Monitoring (CGM) in gestational diabetes mellitus (GDM).
- To explore CGM's role in early dysglycemia detection, treatment optimization, and outcome improvement in GDM pregnancies.
Main Methods:
- Narrative review of existing literature on CGM use in GDM.
- Analysis of CGM's impact on diagnostic value, glycemic pattern identification, and therapeutic guidance.
Main Results:
- CGM provides real-time glucose data, enhancing clinical decisions and patient engagement in GDM care.
- It facilitates earlier detection of hyperglycemia, precise treatment adjustments, and improved glycemic control.
- CGM use is linked to better maternal and neonatal outcomes.
Conclusions:
- CGM shows promise for integrating into routine GDM care, supporting personalized treatment strategies.
- Further research and larger trials are needed to confirm benefits and optimize CGM use in GDM.
- Addressing barriers like cost and access is crucial for wider CGM adoption in GDM management.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Introduction
Complications of Diabetes Mellitus